Clifford Sosin
Clifford Sosin's purchase track record
How the stock did after each of Clifford Sosin's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/9/2024 | CDLX | $2.88M | -68.1% | -56.1% | +14.6% |
| 3/15/2024 | CDLX | $13.92M | -42.0% | -74.3% | +10.0% |
| 1/3/2022 | CDLX | $15.00M | -15.7% | -65.7% | -20.1% |
| 12/1/2021 | CDLX | $2.50M | -6.0% | -60.3% | -9.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
WRLD Announces Q2 2027 Earnings Call. World Acceptance Corporation (WRLD) has announced that it will hold its second quarter 2027 earnings conference call over the internet. The call is scheduled to provide updates on the company's financial performance and outlook for the quarter. Investors can expect to hear details on revenue, expenses, and guidance. The announcement is a routine update and does not indicate any immediate change in the company's fundamentals.
Transaction History
| CDLX | ▼ Sell | Open Market | 200,000 | $225K | 8/19/2025 | View on chart |
| CDLX | ▼ Sell | Open Market | 200,000 | $228K | 8/18/2025 | View on chart |
| CDLX | ▼ Sell | Other | 15,855 | — | 6/30/2025 | View on chart |
| CDLX | ▼ Sell | Other | 754,032 | — | 12/31/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 15,650 | $59K | 12/31/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 15,650 | $59K | 12/30/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 19,523 | $77K | 12/3/2024 | View on chart |
| CDLX | ▼ Sell | Other | 45,126 | — | 6/28/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 3,746 | $34K | 5/13/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 100,000 | $879K | 5/10/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 225,000 | $2.0M | 5/9/2024 | View on chart |
| CDLX | ▼ Sell | Other | 237,563 | — | 4/1/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 350,000 | $5.0M | 3/19/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 350,000 | $4.7M | 3/18/2024 | View on chart |
| CDLX | ▲ Buy | Open Market | 311,715 | $4.3M | 3/15/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 17,155 | $120K | 1/12/2024 | View on chart |
| CDLX | ▼ Sell | Open Market | 37,000 | $328K | 1/2/2024 | View on chart |
| WRLD | ▼ Sell | Open Market | 2,762 | $227K | 4/14/2023 | View on chart |
| WRLD | ▼ Sell | Open Market | 2,700 | $226K | 4/13/2023 | View on chart |
| WRLD | ▼ Sell | Open Market | 5,815 | $478K | 4/3/2023 | View on chart |
| CDLX | ▲ Buy | Open Market | 13,745 | $864K | 1/6/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 56,815 | $3.6M | 1/5/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 84,090 | $5.5M | 1/4/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 75,000 | $5.1M | 1/3/2022 | View on chart |
| CDLX | ▲ Buy | Open Market | 36,875 | $2.5M | 12/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
CDLX: No company news in last 7 days
The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.
CDLX: No company news in last 7 days. The only article in the last week reports that Similarweb’s stock fell after naming a new CEO. This development does not involve Cardlytics, so there is no direct impact on CDLX. The stock remains near its 52‑week low and is trading below its 14‑day RSI of 24.0, indicating a potential oversold condition.